During the past decade, People's Hospital of Hunan Province conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "People's Hospital of Hunan Province" #1 sponsor was "Eli Lilly and Company" with 2 trials, followed by "Guangzhou Institute of Respiratory Disease" with 1 trials sponsored, "Hoffmann-La Roche" with 1 trials sponsored, "Loxo Oncology, Inc." with 1 trials sponsored and "Shanghai Jiao Tong University School of Medicine" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "People's Hospital of Hunan Province" #1 collaborator was "Affiliated Hospital of Nantong University" with 1 trials as a collaborator, "Anhui Provincial Hospital" with 1 trials as a collaborator, "Baotou Central Hospital" with 1 trials as a collaborator, "Central Hospital of Minhang District, Shanghai" with 1 trials as a collaborator and "Changzhi Medical College" with 1 trials as a collaborator. Other collaborators include 54 different institutions and companies that were collaborators in the rest 64 trials.

According to Clinical.Site data, the most researched conditions in "People's Hospital of Hunan Province" are "Chronic Heart Failure" (1 trials), "Complication Rate" (1 trials), "Diagnosis" (1 trials), "Diffuse Parenchymal Lung Diseases" (1 trials) and "Gallbladder Neoplasms" (1 trials). Many other conditions were trialed in "People's Hospital of Hunan Province" in a lesser frequency.

Most popular intervention types in "People's Hospital of Hunan Province" are "Drug" (5 trials), "Procedure" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Abemaciclib" (1 trials), "Abiraterone Acetate" (1 trials), "Carboplatin" (1 trials) and "Cisplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "People's Hospital of Hunan Province" are 8 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "People's Hospital of Hunan Province". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in People's Hospital of Hunan Province, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in People's Hospital of Hunan Province, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".